INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Form 4 transactions

8,590 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
31
CJ
Chakma JustinChief Business Officer
SPRYARS Pharmaceuticals, Inc.
Open-market sale
SELL$267K
30.0K sh
Nov 12, 2025Nov 14, 2025
Page 207 of 215
← PrevNext →
traded Nov 12, 2025
+2d
SEC Form 4

Evidence

31
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$36K
100 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

30
BJ
Baack Jerry J.Director, CEO
BWBBridgewater Bancshares Inc
Open-market sale
SELL$119K
6,993 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

30
CF
Cash Paul FGeneral Counsel & Corp. Secy.
WHWYNDHAM HOTELS & RESORTS, INC.
Option exercise
M$1.94M
36.4K sh
Nov 14, 2025Nov 14, 2025
traded Nov 14, 2025
+0dSEC Form 4

Evidence

30
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$116K
332 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

30
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$232K
664 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

30
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Tax withholding
F$2.98M
9,532 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

57
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$1.53M
32.7K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

54
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$424K
10.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

54
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$11.38M
17.5K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

54
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$13.50M
20.7K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

54
KD
Karydas DaphneDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$463K
10.1K sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

54
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$20.10M
30.9K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

54
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$17.44M
26.8K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

54
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$12.58M
19.2K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

53
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$1.79M
38.9K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$2.81M
4,367 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$6.14M
9,392 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.55M
2,399 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.43M
2,201 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$235K
5,000 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

51
KD
Karydas DaphneDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$226K
4,885 sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$6.24M
9,619 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.76M
2,684 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

51
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$1.42M
2,194 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

50
GP
Gu PaulDirector, Chief Technology Offier
UPSTUpstart Holdings, Inc.
Open-market purchase
BUY$3.14M
80.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

50
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$593K
12.7K sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

49
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$5.15M
112.3K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

48
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$315K
480 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

48
DS
Dewan SameerSenior Vice President
GGenpact LTD
Open-market sale
SELL$1.19M
26.5K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

48
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$988K
1,535 sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence

47
GP
Gu PaulDirector, Chief Technology Offier
UPSTUpstart Holdings, Inc.
Open-market purchase
BUY$784K
20.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

47
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$233K
5,000 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

47
GM
Gold Alexander MDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$91K
1,933 sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC Form 4

Evidence

46
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$359K
8,485 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

46
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$473K
11.3K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

46
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$382K
8,456 sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

46
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$539K
13.0K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

45
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$1.54M
32.9K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

45
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$1.32M
29.2K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K